Yubo International Biotech LTD YBGJ
We take great care to ensure that the data presented and summarized in this overview for Yubo International Biotech Ltd is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in YBGJ
Top Purchases
Top Sells
About YBGJ
Yubo International Biotech Limited, thorough its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is based in Beijing, China.
Insider Transactions at YBGJ
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 09
2022
|
Lina Liu Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
4,728,000
-34.19%
|
$0
$0.5 P/Share
|
|
Sep 23
2022
|
Focus Draw Group LTD |
SELL
Open market or private sale
|
Direct |
4,728,000
-34.19%
|
$0
$0.5 P/Share
|
|
Jan 14
2021
|
Lina Liu Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
13,829,400
+50.0%
|
-
|
|
Jan 14
2021
|
Lina Liu Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
116,697,438
-100.0%
|
-
|
|
Jan 14
2021
|
Wang Yang |
BUY
Open market or private purchase
|
Indirect |
19,211,400
+50.0%
|
-
|
|
Jan 14
2021
|
Wang Jun President and CEO |
BUY
Open market or private purchase
|
Indirect |
39,943,800
+50.0%
|
-
|